Tower Research Capital (TRC)’s iKang Healthcare Group, Inc. KANG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-1,235
Closed -$25K 4706
2018
Q4
$25K Buy
1,235
+1,047
+557% +$18.6K ﹤0.01% 1779
2018
Q3
$3K Sell
188
-9,496
-98% -$183K ﹤0.01% 3386
2018
Q2
$198K Buy
+9,684
New +$195K 0.01% 1078
2018
Q1
Sell
-2,931
Closed -$46K 4218
2017
Q4
$46K Buy
+2,931
New +$42.3K 0.01% 1401
2017
Q1
Sell
-500
Closed -$9K 4390
2016
Q4
$9K Sell
500
-524
-51% -$8.87K ﹤0.01% 2743
2016
Q3
$19K Buy
1,024
+943
+1,164% +$17.3K ﹤0.01% 1664
2016
Q2
$1K Sell
81
-756
-90% -$15.2K ﹤0.01% 4299
2016
Q1
$18K Buy
837
+502
+150% +$10.5K ﹤0.01% 1455
2015
Q4
$7K Sell
335
-599
-64% -$10.3K ﹤0.01% 2670
2015
Q3
$14K Buy
934
+834
+834% +$13.5K ﹤0.01% 2067
2015
Q2
$2K Buy
+100
New +$1.84K ﹤0.01% 3853

Tower Research Capital (TRC)'s KANG Position: Q1 2019 in Review

Tower Research Capital (TRC) sold out of iKang Healthcare Group, Inc. (KANG) in Q1 2019, closing a stake of 1,235 shares — an estimated $25K sold.

Tower Research Capital (TRC) first reported a position in KANG in Q2 2015 and held it in 11 quarters. The position peaked at $198K in Q2 2018. 0 funds tracked by Wall St. Rank hold KANG as of Q1 2019.

  • Tower Research Capital (TRC) reported no remaining iKang Healthcare Group, Inc. position as of Q1 2019 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,235 iKang Healthcare Group, Inc. shares in Q1 2019, an estimated $25K.
  • Tower Research Capital (TRC) first reported a position in iKang Healthcare Group, Inc. in Q2 2015 and held it in 11 quarters.
  • Tower Research Capital (TRC)'s iKang Healthcare Group, Inc. position peaked at $198K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held iKang Healthcare Group, Inc. as of Q1 2019.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2019, filed 14 May 2019.